Company intelligence / Profile preview

Bio Pros

Ownership: Private
Development stage: Commercial

Overview

Sells a non-synthetic growth factor product ("BioPro+") marketed as a drug-free alternative to human growth hormone therapy. Claims include improved energy, metabolism, sleep quality and workout recovery. No clinical trial data provided; results are based on user testimonials and physician endorsements.

Therapeutic areas: Metabolic DisordersEndocrinologyNeurology
Modalities: ProteinGrowth factor supplement
Industry: Food & Nutrition

Drug pipeline

5 assets

BIO-SEPTIC PRO

Commercial

Indications: Septic system maintenance

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Bio Pros.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio Pros.

Explore the full profile